Safety analysis of repeated high doses of samarium-153 lexidronam in men with hormone-naive prostate cancer metastatic to bone. [electronic resource]
Producer: 20080724Description: 40-5 p. digitalISSN:- 1558-7673
- Adenocarcinoma -- drug therapy
- Aged
- Aged, 80 and over
- Analgesics, Non-Narcotic -- administration & dosage
- Bone Neoplasms -- drug therapy
- Dose-Response Relationship, Drug
- Feasibility Studies
- Humans
- Male
- Middle Aged
- Neoplasms, Hormone-Dependent -- pathology
- Organometallic Compounds -- administration & dosage
- Organophosphorus Compounds -- administration & dosage
- Prostatic Neoplasms -- pathology
- Samarium
- Survival Rate
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.